Marjolein Kok Selected Research

Breech Presentation

9/2018	Development and internal validation of a clinical prediction model for external cephalic version.
1/2017	Atosiban versus fenoterol as a uterine relaxant for external cephalic version: randomised controlled trial.
5/2015	Implementation of client versus care-provider strategies to improve external cephalic version rates: a cluster randomized controlled trial.
12/2014	Implementation of external cephalic version in the Netherlands: a retrospective cohort study.
6/2014	Mode of delivery after successful external cephalic version: a systematic review and meta-analysis.
3/2014	Facilitators and barriers to external cephalic version for breech presentation at term among health care providers in the Netherlands: a quantitative analysis.
3/2013	Patient's willingness to opt for external cephalic version.
8/2008	Nifedipine as a uterine relaxant for external cephalic version: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marjolein Kok Research Topics

Disease

8	Breech Presentation 09/2018 - 08/2008
7	Premature Birth (Birth, Premature) 11/2019 - 01/2016
5	Premature Obstetric Labor (Premature Labor) 01/2018 - 03/2015
2	Rupture 10/2016 - 09/2016
1	COVID-19 12/2022
1	Pain (Aches) 12/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2018
1	Uterine Hemorrhage (Uterine Bleeding) 02/2017
1	Bronchopulmonary Dysplasia 10/2016
1	Preterm Premature Rupture of the Membranes 10/2016
1	Perinatal Death 10/2016
1	Nausea 01/2016
1	Hyperemesis Gravidarum 01/2016
1	Dehydration (Water Stress) 01/2016
1	Vomiting 01/2016
1	Gestational Weight Gain 01/2016
1	Malnutrition (Nutritional Deficiencies) 01/2016
1	Birth Weight (Birth Weights) 01/2016
1	Fetal Distress 06/2014
1	Dystocia 06/2014
1	Pneumothorax 03/2014
1	Asphyxia (Suffocation) 03/2014
1	Meningitis 03/2014
1	Oligohydramnios 02/2013

Drug/Important Bio-Agent (IBA)

6	Fibronectins (Fibronectin)IBA 11/2019 - 07/2015
4	atosibanIBA 11/2019 - 05/2016
3	Nifedipine (Adalat)FDA LinkGeneric 10/2016 - 08/2008
2	FenoterolIBA 09/2018 - 01/2017
1	Insulin-Like PeptidesIBA 11/2019
1	Insulin (Novolin)FDA Link 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2017
1	Soaps (Soap)IBA 02/2017
1	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 05/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2016
1	SmokeIBA 01/2016

Therapy/Procedure

8	Fetal Version (External Cephalic Version) 01/2017 - 08/2008
3	Tocolysis 10/2016 - 03/2015
3	Cesarean Section (Caesarean Section) 09/2016 - 03/2013
2	Pessaries 01/2018 - 12/2016
1	Episiotomy 12/2022
1	Therapeutics 01/2018
1	Enteral Nutrition (Feeding, Tube) 01/2016
1	Length of Stay 01/2016
1	Aftercare (After-Treatment) 01/2016
1	Induced Labor 01/2016
1	Neonatal Intensive Care 03/2014
1	Contraindications 02/2013